These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22458771)

  • 21. Subacute cutaneous lupus erythematosus exacerbated or induced by chemotherapy.
    Funke AA; Kulp-Shorten CL; Callen JP
    Arch Dermatol; 2010 Oct; 146(10):1113-6. PubMed ID: 20956642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-induced subacute cutaneous lupus erythematosus: a paradigm for bedside-to-bench patient-oriented translational clinical investigation.
    Sontheimer RD; Henderson CL; Grau RH
    Arch Dermatol Res; 2009 Jan; 301(1):65-70. PubMed ID: 18797894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subacute cutaneous lupus erythematosus presenting as poikiloderma.
    Hughes R; Loftus B; Kirby B
    Clin Exp Dermatol; 2009 Dec; 34(8):e859-61. PubMed ID: 20055848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-17 in cutaneous lupus erythematosus.
    Tanasescu C; Balanescu E; Balanescu P; Olteanu R; Badea C; Grancea C; Vagu C; Bleotu C; Ardeleanu C; Georgescu A
    Eur J Intern Med; 2010 Jun; 21(3):202-7. PubMed ID: 20493423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal DNA methylation in T cells from patients with subacute cutaneous lupus erythematosus.
    Luo Y; Li Y; Su Y; Yin H; Hu N; Wang S; Lu Q
    Br J Dermatol; 2008 Sep; 159(4):827-33. PubMed ID: 18644019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumour necrosis factor alpha is expressed in refractory skin lesions from patients with subacute cutaneous lupus erythematosus.
    Zampieri S; Alaibac M; Iaccarino L; Rondinone R; Ghirardello A; Sarzi-Puttini P; Peserico A; Doria A
    Ann Rheum Dis; 2006 Apr; 65(4):545-8. PubMed ID: 16096331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients.
    Vera-Recabarren MA; García-Carrasco M; Ramos-Casals M; Herrero C
    Br J Dermatol; 2010 Jan; 162(1):91-101. PubMed ID: 19785596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do selected drugs increase the risk of lupus? A matched case-control study.
    Schoonen WM; Thomas SL; Somers EC; Smeeth L; Kim J; Evans S; Hall AJ
    Br J Clin Pharmacol; 2010 Oct; 70(4):588-96. PubMed ID: 20840450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Terbinafine-induced subacute cutaneous lupus erythematosus.
    Hivnor CM; Hudkins ML; Bonner B
    Cutis; 2008 Feb; 81(2):156-7. PubMed ID: 18441768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Subacute cutaneous lupus erythematosus induced by terbinafine].
    Amitay-Layish I; Feuerman H; David M
    Harefuah; 2006 Jul; 145(7):480-2, 552. PubMed ID: 16900733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tyrosine kinase 2 and interferon regulatory factor 5 polymorphisms are associated with discoid and subacute cutaneous lupus erythematosus.
    Järvinen TM; Hellquist A; Koskenmies S; Einarsdottir E; Koskinen LL; Jeskanen L; Berglind L; Panelius J; Hasan T; Ranki A; Kere J; Saarialho-Kere U
    Exp Dermatol; 2010 Feb; 19(2):123-31. PubMed ID: 19758313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Case report: verapamil-induced subacute cutaneous lupus erythematosus.
    Kurtis B; Larson MJ; Hoang MP; Cohen JB
    J Drugs Dermatol; 2005; 4(4):506-8. PubMed ID: 16004027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paraneoplastic subacute cutaneous lupus erythematosus: an underrecognized entity.
    Evans KG; Heymann WR
    Cutis; 2013 Jan; 91(1):25-9. PubMed ID: 23461055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anastrozole-induced subacute cutaneous lupus erythematosus.
    Fisher J; Patel M; Miller M; Burris K
    Cutis; 2016 Aug; 98(2):E22-6. PubMed ID: 27622265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proton pump inhibitor induced subacute cutaneous lupus erythematosus: Clinical characteristics and outcomes.
    Poh YJ; Alrashid A; Sangle SR; Higgins E; Benton E; McGibbon D; D'Cruz DP
    Lupus; 2022 Aug; 31(9):1078-1083. PubMed ID: 35635045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proton pump inhibitors-related subacute cutaneous lupus erythematosus: Clinical characteristics, management, and outcome.
    Deng Z; Guo A; Wu C; Wang C
    J Cosmet Dermatol; 2022 Dec; 21(12):7202-7208. PubMed ID: 36214602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subacute cutaneous lupus erythematosus following ribociclib therapy for metastatic breast cancer.
    Collada Sánchez VL; Álvarez Criado J; Martinez Martin V; Zamora Auñon P; Espinosa Arranz E; Mayor Ibarguren A; Nacher Jimenez I; Herrero Ambrosio A
    J Oncol Pharm Pract; 2023 Oct; 29(7):1793-1796. PubMed ID: 37455486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-induced subacute cutaneous lupus erythematosus related to doxycycline.
    Miller KK; Chu J; Patel R; Kamino H
    Dermatol Online J; 2011 Oct; 17(10):3. PubMed ID: 22031629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leflunomide in subacute cutaneous lupus erythematosus - two sides of a coin.
    Suess A; Sticherling M
    Int J Dermatol; 2008 Jan; 47(1):83-6. PubMed ID: 18173611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A difficult diagnosis: drug-induced subacute cutaneous lupus erythematosus (SCLE) triggered by omeprazole in a patient with pre-existing idiopathic SCLE.
    Wee JS; Natkunarajah J; Marsden RA
    Clin Exp Dermatol; 2012 Jun; 37(4):445-6. PubMed ID: 22420369
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.